Samuel Andrews, MD
Radiation Oncology · Iowa City, IANPI 1851508337
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 8.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $188 and has fallen 85.2% since, to $28 in 2024.
Across 23 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$35
- Servier Pharmaceuticals LLC$35
- Stemline Therapeutics Inc.$34
- Boehringer Ingelheim$33
- Bayer$32
- AVEO Pharmaceuticals, Inc.$28
- plus $228 from 12 others
What the payments were for
- Food & beverage$425100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 2 | $35 |
| Servier Pharmaceuticals LLC | 2 | $35 |
| Stemline Therapeutics Inc. | 1 | $34 |
| Boehringer Ingelheim | 2 | $33 |
| Bayer | 2 | $32 |
| AVEO Pharmaceuticals, Inc. | 2 | $28 |
| Boston Scientific | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Eisai Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $20 |
| Amgen | 1 | $18 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $17 |
| Seagen Inc. | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $16 |
| Incyte Corporation | 1 | $16 |
| Coherus Oncology, Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
How this compares
$425 in reported general payments places this provider in the 65th percentile of 55 radiation oncology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Iowa City
- Kristin PlichtaIowa City$6K
- Malgorzata KozakIowa City$2K
- Mark SmithIowa City$2K
- Addison WillettIowa City$1K
- Bryan AllenIowa City$552
- John BuattiIowa City$419
- Kailin YangIowa City$224
- Shri Kiriti RajanIowa City$71
- Uwajachukwumma UzomahIowa City$71
- William RockeyIowa City$70
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.